Results

Alzamend Neuro Inc.

05/17/2022 | Press release | Distributed by Public on 05/17/2022 06:05

Alzamend Neuro Announces Pre-IND Submission for AL001 as a Treatment of Bipolar Disorder, Major Depressive Disorder and Post-Traumatic Stress Disorder